Recently, genome wide association studies using exome sequencing have resulted in the discovery of a series of rare mutations in triggering receptor expressed on myeloid cells 2 (TREM2) gene, including R47H, which may increase the risk of AD by three-fold [4,5,6]. The gene discussed is TREM2; the disease is Alzheimer disease.